Advertisements

Coralium-D3

Quick links to important sections

Coralium-D3

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Coralium-D3

This foundational section establishes the identity, composition, and general purpose of Coralium-D3, strictly adhering to verifiable facts without detailing specific treatments, dosages, or safety information.

Property Description
Active Ingredients Elemental Calcium, Cholecalciferol (Vitamin D3)
Form Oral Tablet (e.g., film-coated tablet), Syrup, Suspension
Pharmacological Class Mineral Supplement, Vitamin D Analog
General Purpose Correcting deficiencies in calcium and Vitamin D, supporting bone health
Origin Derived (often utilizes Coral Grains as a natural source for calcium)

What is Coralium-D3 and Its Pharmacological Classification?

Coralium-D3 is a fixed-dose combination product classified as a nutritional supplement within the therapeutic category of Mineral supplements and Vitamin D analogs. The preparation's primary objective is to supply essential micronutrients necessary for maintaining the body's proper mineral balance. It is notable for its positioning as a comprehensive solution for dual deficiency, which is clinically recognized for optimizing compliance compared to taking separate supplements. Fixed combinations of Calcium and Vitamin D are widely accepted for their utility in supplementation protocols.


What are the Active Ingredients and Dosage Forms of Coralium-D3?

The active ingredients in Coralium-D3 are Elemental Calcium and Cholecalciferol (Vitamin D3). The calcium component is commonly derived from Calcium Carbonate, which, in this formulation, is distinctively sourced from natural sources such as highly refined Coral Grains. Cholecalciferol is defined chemically as a fat-soluble secosteroid. This preparation is generally supplied for the oral route of administration in several forms, most commonly an oral tablet (often film-coated for easier swallowing), but also sometimes as an oral syrup or suspension.


What is the General Purpose of Coralium-D3?

The general purpose of Coralium-D3 is to facilitate bone formation and maintenance by addressing a potential dual deficiency. The synergistic combination is essential because the Cholecalciferol component actively functions as a prohormone that is required for maximizing the body's intestinal absorption of calcium. Research confirms that Vitamin D plays a fundamental role in calcium homeostasis. By supplying both the mineral and the vitamin responsible for its utilization, the preparation supports bone density and overall skeletal integrity.

Advertisements

What side effects are possible with Coralium-D3?

Possible Side Effects and Safety Information

The safety profile for this combination product, containing Elemental Calcium and Cholecalciferol (Vitamin D3), is defined by official regulatory documents through adverse reaction classification and mandatory safety constraints.


Frequency-Classified Adverse Reactions

The most commonly classified effects relate to mineral metabolism and the gastrointestinal system.

Classification System-Organ Class Reactions
Uncommon (ge 1/1,000 to < 1/100) Metabolism and nutrition disorders Hypercalcaemia, Hypercalciuria
Rare (ge 1/10,000 to < 1/1,000) Gastrointestinal disorders Constipation, flatulence, nausea, abdominal pain, diarrhoea
Very Rare (le 1/10,000) Metabolism and nutrition disorders Milk-alkali syndrome

Serious Adverse Reactions and Constraints

The most serious safety concerns documented involve outcomes of hypervitaminosis D and prolonged, severe Hypercalcaemia. These conditions can lead to irreversible renal damage (including nephrocalcinosis) and soft tissue calcification. Cardiac arrhythmias are also documented in severe cases of hypercalcaemia.

Use of Coralium-D3 is contraindicated in patients with pre-existing conditions that cause high mineral levels, such as Hypercalcaemia, Hypercalciuria, Hypervitaminosis D, and severe renal impairment.

Specific regulatory caution is mandated for patients with renal impairment, sarcoidosis, or a history of nephrolithiasis. For long-term treatment, regulatory documents specify the requirement for regular monitoring of serum calcium levels and renal function to prevent metabolic complications.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

Feature Official Regulatory Statement or Documentation
Documented Overdose Presentations Overdose is documented to cause Hypercalcemia and Hypervitaminosis D. Early signs include anorexia, nausea, vomiting, constipation, fatigue, muscle weakness, polydipsia (excessive thirst), and polyuria (frequent urination).
Physiological systems affected (as stated in label) The regulatory documents list effects on the Gastrointestinal, Neurological, Renal (nephrocalcinosis, irreversible renal damage), and Cardiovascular systems (cardiac arrhythmias in severe cases).
Dose-related or exposure-related factors (if applicable) Overdose risk is associated with excessive intake, with heightened risk documented in patients who have impaired renal function or existing conditions like sarcoidosis.
Population-specific overdose notes (if applicable) Overdoses must be avoided in pregnant women due to officially documented risks of adverse effects on the developing fetus.

Overdose Classifications

Classification Official Regulatory Wording or Concept
Severity classification (as defined in official documents) Can result in severe hypercalcemia, leading to coma and death in extreme, unmanaged cases, and causing long-term irreversible renal damage.
Regulatory basis (EMA / FDA / etc.) Based on the Summary of Product Characteristics (SmPC) / Prescribing Information.
Overdose-context constraints (as defined in official documents) No specific antidote is known for reversing the effects; management is officially defined as symptomatic and supportive.

Resulting Overdose Structure

  • Overdose is primarily characterized by the development of hypercalcemia and is officially documented to present with symptoms such as anorexia, nausea, vomiting, polyuria, and fatigue.
  • Severe outcomes explicitly documented in regulatory labeling include cardiac arrhythmias, renal impairment, nephrocalcinosis, and potential progression to coma or death.
  • Patients must stop treatment immediately if an overdose is suspected and seek immediate medical attention, particularly if severe symptoms such as seizures or difficulty breathing are present.
  • The required management procedures documented in the label include rehydration, monitoring of serum calcium and renal function, and the use of pharmacological agents like diuretics or corticosteroids to manage the elevated calcium levels.

Connection to the overall overdose profile: Regulatory documents define the overdose profile of this combination product based on the physiological toxicity of hypercalcemia and hypervitaminosis D. This official documentation lists specific clinical manifestations and severe systemic outcomes, such as renal or cardiac damage. Consequently, regulatory authorities mandate the immediate cessation of the product and require urgent medical intervention when these documented signs or severe conditions occur. The management procedures listed are strictly supportive and symptomatic, reflecting the official statement that no specific antidote is known.

Advertisements

Therapeutic Uses of Coralium-D3

What Coralium-D3 Treats: Main Uses and Benefits

Coralium-D3 is commonly used to help with conditions that present with systemic or localized discomfort related to nutritional needs, and contributes to easing associated symptomatic distress. The key areas it helps manage include symptoms related to systemic imbalance affecting the skeleton, symptoms of increased neurological or muscular activity, and supportive care when symptoms intensify due to heightened need.

The core therapeutic areas include the management and support of patients with low Vitamin D and Calcium levels, and use may be part of symptomatic management for patients addressing osteoporosis who are also experiencing deficiency.

Symptom Relief Across Key Domains

Coralium-D3 plays a role in managing symptom clusters that may become intense or disruptive, such as discomfort in conditions like osteomalacia or muscle cramps and spasms that stem from systemic imbalance. It is also used when supportive symptom management is appropriate during periods of increased need, like in advanced age or pregnancy. This assistance supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load.


Quick Fact: Symptomatic Support for Muscular Distress

This medication is commonly used to help with symptoms related to increased neurological or muscular activity, which can create noticeable functional strain. It assists with maintaining a sense of stability when symptoms are more noticeable.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Coralium-D3?

Eligibility for Coralium-D3 (a combination of Calcium and Cholecalciferol) is strictly defined by official regulatory documentation, focusing on patient health status and pre-existing conditions.

The medicine is formally allowed for adults and older adults to address documented Calcium and Vitamin D deficiencies. The specific high-dose formulation is not recommended for children and adolescents.

Use is contraindicated (absolutely prohibited) in several patient populations. These include individuals with high levels of calcium in the blood (Hypercalcaemia) or urine (Hypercalciuria), those with excessively high levels of Vitamin D (Hypervitaminosis D), and patients suffering from Severe Renal Impairment or Nephrolithiasis (kidney stones). Patients with known hypersensitivity to the active ingredients must also not use the medicine.

Use requires caution and monitoring for groups like patients with Sarcoidosis, those who are immobilized with osteoporosis, or those with mild to moderate renal impairment. During pregnancy and lactation, use is only permitted if strictly indicated to correct a deficiency, with regulatory limits to prevent the risk of Vitamin D overdose.

Advertisements

What should I know about interactions with other medicines?

This section details the officially documented interaction profile of Coralium-D3 (Calcium Carbonate and Cholecalciferol combination product), derived strictly from authoritative government regulatory documents.

Absorption Interference and Timing Rules

Co-administration with the calcium component reduces the systemic exposure of several medicines, including Tetracycline and Quinolone antibiotics, Levothyroxine, Bisphosphonates, and Sodium Fluoride. This absorption interference necessitates strict time separation rules documented in regulatory labeling. For instance, specific antibiotics must be administered two hours before or six hours after calcium intake, and Levothyroxine requires at least four hours separation.

Pharmacodynamic Risks and Restrictions

Pharmacodynamic interactions increase risk with drugs like Cardiac Glycosides (Digoxin) and Thiazide Diuretics. Hypercalcaemia, associated with this treatment, may potentiate the toxic effects of cardiac glycosides, mandating monitoring of serum calcium levels and ECG. Regulatory labeling also advises against co-administration with other Vitamin D Analogs (e.g., Calcitriol) due to additive effects and increased hypercalcaemia risk.

Metabolic and Food Interactions

Metabolic interactions exist where drugs such as Phenytoin and Barbiturates can increase the breakdown of the Vitamin D3 component, resulting in a decreased effect of Coralium-D3. Furthermore, foods high in Oxalic Acid (spinach) or Phytic Acid (whole cereals) require a minimum two-hour separation from administration to avoid absorption inhibition.

Advertisements

Mechanism of Action

Coralium-D3 exerts its primary effects by acting as a high-affinity agonist for the nuclear Vitamin D Receptor (VDR). This receptor is widely expressed in peripheral tissues and functions as a transcription factor. Upon binding, the active metabolite and the VDR form a complex that regulates the transcription of target genes by interacting with specific DNA sequences. This process dictates the synthesis of proteins required for various systemic functions, establishing the mechanism's physiological scope.

The VDR-mediated gene regulation principally modulates the calcium and phosphate ion concentrations in the circulation. It achieves this by regulating mineral absorption in the intestine, reabsorption in the kidney, and the turnover of minerals within bone. Furthermore, the mechanism adjusts the synthesis and release of Parathyroid Hormone (PTH) via negative feedback.

Due to VDR expression in immune cells, Coralium-D3 also engages in pleiotropic action, influencing immune cell proliferation and the balance of pro- and anti-inflammatory cytokines, thereby affecting local and systemic immune activity.

Advertisements

Dosage and Administration Information

How to Use Coralium-D3: General Administration Guidelines

Coralium-D3 is a fixed-dose combination product of elemental calcium and cholecalciferol (Vitamin D3) that is designated for oral administration exclusively. Usage must follow the instructions established for this product, which define the standard regimen and specific conditions for proper intake.

General Administration Guidelines

Instruction Entity Standard Guidelines
Route of administration Oral use exclusively.
Standard Dosing Schedule The standard adult regimen is typically one unit (e.g., tablet) twice daily as a divided dose to achieve the required daily maintenance intake.
Timing in relation to meals Recommended to be taken with meals or within one and a half hours of a meal to optimize absorption of the calcium component.
Preparation requirements Chewable tablets must be completely chewed or sucked. Film-coated tablets must be swallowed whole with water or juice and not chewed.
Missed-dose rules If a dose is missed, it should be skipped. The patient must resume the regular schedule, and a double dose must not be taken to compensate.
Population-specific rules The daily intake must not exceed a maximum limit (e.g., 1500 mg calcium and 600 IU Vitamin D) during pregnancy. The product is not intended for use in patients with severe renal impairment.

Procedural Protocol

To ensure proper administration, official guidelines mandate that the intake of Coralium-D3 must be separated from other specific oral medications, such as tetracycline antibiotics or bisphosphonates, by several hours. This separation is required to prevent a reduction in the absorption of the active ingredients. Treatment is often prescribed for long-term use to support mineral balance.

Advertisements

Recent Clinical Evidence

Research Evidence: Overview of Studies for Coralium-D3

This summary describes the available research concerning the fixed combination of Elemental Calcium and Cholecalciferol (Vitamin D3), focusing on the types of clinical studies conducted, the outcomes they measured, and the overall consistency of the scientific findings. This information is strictly descriptive and does not offer any clinical guidance or treatment recommendations.


1. Evidence for Support in Fracture Risk Contexts

Research was evaluated in contexts associated with fracture risk, primarily through large Randomized Controlled Trials (RCTs) and Systematic Reviews. Researchers studied outcomes such as the incidence of total fractures and hip fractures in populations of older adults (≥ 60 years), including both community-dwelling and institutionalized individuals.

Findings were not uniform: patterns related to fracture outcomes were observed in specific sub-groups, such as institutionalized residents or participants with documented low baseline Vitamin D levels. In research examining the general community-dwelling population, findings were often characterized as mixed or inconsistent.


2. Evidence for Managing Bone Mineral Density and Deficiency

The research base for this indication is supported by RCTs and Systematic Reviews that monitored outcomes related to the body's mineral balance and function. Studies tracked the biomarker 25-hydroxyvitamin D [25(OH)D] status and changes in Bone Mineral Density (BMD).

Research describes patterns related to a shift in 25(OH)D levels in populations diagnosed with dual deficiency or insufficiency. Changes monitored in BMD measurements in these groups were often described as minimal or difficult to distinguish from control groups.


3. Consistency, Limitations, and Research Gaps

The existing research base presents several points of limitation. Systematic reviews note the inconsistency of findings when aggregating results from trials that used differing doses and regimens.

Data show patterns related to outcomes that appear dependent on the participants’ underlying baseline deficiency status. Furthermore, long-term effects beyond a few years are not fully established, and data for certain groups remain insufficient, particularly for pediatric populations.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Coralium-D3 (FAQ)

Q: What is the main reason doctors prescribe Coralium-D3?

Regulatory documents state that Coralium-D3 (a combination of Calcium and Cholecalciferol) is formally indicated for two main purposes: the prevention and treatment of combined calcium and vitamin D deficiencies and as an adjuvant (supplementary) treatment alongside specific therapies for osteoporosis.


Q: How long do the effects of Coralium-D3 last after taking it?

The effects of the medicine’s components are known to persist for an extended period. The Vitamin D component, Cholecalciferol, is fat-soluble and is stored in the body. The main circulating form of the vitamin D component has a half-life of approximately 15 days, meaning it remains in the circulation for a substantial time after administration.


Q: Can Coralium-D3 be used for more than one health issue?

Yes. Official product information confirms that Coralium-D3 is indicated to correct deficiencies in calcium and vitamin D. In addition, it is used as an adjuvant (or supplement) alongside other medical therapies for conditions like osteoporosis.


Q: What's the difference between Coralium-D3 and regular Vitamin D3 supplements?

Coralium-D3 is a fixed-dose combination product. This means it contains two active ingredients: Elemental Calcium and Cholecalciferol (Vitamin D3). Regular Vitamin D3 supplements, by contrast, contain only the cholecalciferol component.


Q: Does Coralium-D3 have an effect on sleep?

The medicine’s official safety profile does not list a direct effect on sleep. However, general side effect information indicates that feelings of drowsiness or fatigue may occur as symptoms of hypercalcaemia (excessive calcium in the blood), which is listed as an uncommon side effect.


Q: Can Coralium-D3 cause headaches?

Headache is not listed as a common or rare side effect in official safety reports. However, a continuing headache is described as a possible sign of a very rare, severe complication (milk-alkali syndrome).


Q: Does Coralium-D3 interact with blood pressure medications?

Yes, co-administration with certain blood pressure medications requires caution. Official labels warn that the risk of excessive blood calcium levels (hypercalcaemia) is increased when the medicine is taken alongside Thiazide Diuretics.


Q: Can I take Coralium-D3 if I'm already taking pain relievers?

The calcium component may affect the absorption of certain other oral medications, requiring time separation. Furthermore, official documents indicate that Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) may worsen gastrointestinal irritation when taken with a similar product.


Q: Are there special warnings for people with liver problems taking Coralium-D3?

Official information indicates that the medicine is processed in the liver, and caution is generally advised. No specific dose adjustment is usually required for patients with mild liver impairment.


Q: What is the risk classification of Coralium-D3?

Coralium-D3 is classified as a nutritional supplement and Vitamin D Analog. Specific high-dose regimens are restricted during pregnancy due to the risk of fetal harm if Vitamin D overdose occurs.


Q: Why do some people stop taking Coralium-D3?

According to official side effect profiles, the most common patient-reported reasons for discontinuation related to side effects are gastrointestinal issues such as constipation, flatulence, and nausea. These are listed as rare effects.


Q: Does Coralium-D3 interact with common dietary supplements like magnesium or calcium?

Yes. Regulatory documents advise against co-administration with other high-dose Vitamin D Analogues. Magnesium supplements should also be taken with caution, especially by those with reduced kidney function, as there is a risk of high magnesium blood levels.


Q: Is Coralium-D3 the same as Calcitriol?

No, they are different forms of Vitamin D. Coralium-D3 contains Cholecalciferol (Vitamin D3), which is a precursor that requires activation in the body. Calcitriol is the active, hormonal form of Vitamin D.


Q: Why does Coralium-D3 come in different colors/forms (e.g., tablet vs. capsule)?

The product is supplied in multiple forms (e.g., chewable tablets, film-coated tablets) to allow for flexibility in administration. This provision is described as being for different patient needs, such as difficulty swallowing.


Q: Can Coralium-D3 affect laboratory test results?

Yes. Because the medicine contains calcium and vitamin D, it can influence laboratory results by increasing blood and urine levels of calcium (hypercalcaemia/hypercalciuria). Official guidelines specify the requirement for regular monitoring of these levels during long-term treatment.


Q: Is Coralium-D3 addictive?

No. Official regulatory classifications confirm that Coralium-D3 is a vitamin analog and mineral supplement. It is not classified as a controlled substance and has no known abuse or addictive potential.


Q: Does Coralium-D3 contain lactose or gluten?

The presence of inactive ingredients (excipients) like lactose or gluten depends on the specific formulation. Many film-coated tablets may contain lactose. Information regarding sensitivities or allergies is provided on the specific product packaging and through a pharmacist.


Q: Is Coralium-D3 a controlled substance?

No. Official regulatory agencies do not classify Coralium-D3 as a controlled substance.


Q: Are the side effects of Coralium-D3 temporary?

Common gastrointestinal side effects like nausea and flatulence are generally considered temporary and may subside with continued use or if the medicine is taken with food. However, serious effects related to prolonged, high calcium levels, such as kidney damage, are irreversible.


Q: Does Coralium-D3 have any known interactions with herbal products?

Regulatory documents state that there is not enough information to confirm safety or interactions with most herbal remedies and supplements. This is because they are not tested in the same way as approved medicines.


Q: Can Coralium-D3 cause weight gain or loss?

Weight changes are not listed as a common side effect in official adverse reaction reports. It is noted, however, that weight loss may occur as an indication of high blood calcium levels (hypercalcaemia) or overdose.


Q: How is the safety of Coralium-D3 monitored by health agencies?

Safety is continuously tracked through Post-Marketing Surveillance and mandatory reporting of serious adverse reactions to health agencies. Furthermore, regulatory guidelines require physicians to perform regular monitoring of patients' serum calcium levels and renal function to prevent metabolic complications during long-term use.


Q: Can men and women use Coralium-D3 for the same conditions?

Yes, the indications for use, such as correcting deficiencies or supplementary osteoporosis therapy, are generally the same for all adults. The only specific difference in regulatory guidelines applies to women during pregnancy and lactation, who have specific intake limits.


Q: Why is Coralium-D3 prescribed when standard treatments don't work?

This medicine is not typically positioned as a second-line treatment when others fail. Instead, it is frequently prescribed in conjunction with (as a necessary supplement to) other specific treatments, particularly those used for osteoporosis management.


Q: What is the half-life of Coralium-D3?

Pharmacokinetic data indicates that the Cholecalciferol (Vitamin D3) component is metabolized into a major circulating form in the blood. This form has a half-life of approximately 15 days, meaning it takes several weeks for the amount in the body to significantly decrease.


Q: Does Coralium-D3 have a black box warning?

No. Based on available prescribing information for the active ingredients (Calcium and Cholecalciferol), Coralium-D3 does not carry a formal FDA Boxed Warning (often referred to as a 'Black Box Warning').

Advertisements

How should Coralium-D3 be stored and disposed of?

Official Storage and Disposal Requirements

Coralium-D3 must be stored strictly according to the conditions mandated by official regulatory labeling to protect the stability of the Elemental Calcium and Cholecalciferol (Vitamin D3).


Storage Conditions

Requirement Official Instruction
Temperature Store below 25 C or 30 C; do not freeze.
Protection Store in the original container, protected from light and moisture.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Do not use the medicine after the labeled expiry date (EXP). Unused or expired Coralium-D3 must not be thrown away via wastewater or regular household waste. Disposal must be performed according to local regulations for pharmaceutical products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Coralium-D3 found in:

A-Z Index: